[1]
Duvic, M. 2009. Epigenetic approaches. Histone deacetylase inhibitors: vorinostat. A new treatment option for advanced cutaneous T-cell lymphoma. Hematology Meeting Reports (formerly Haematologica Reports). 3, 1 (Jun. 2009). DOI:https://doi.org/10.4081/hmr.v3i1.525.